Enovis Corp Share-based Payment Arrangement, Expense
Enovis Corp (ENOV) reported Share-based Payment Arrangement, Expense of $8.90 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Enovis Corp share-based payment arrangement, expense for the quarter ending 2026-07-03 was $8.90M, a 2.70% increase year-over-year.
- Enovis Corp share-based payment arrangement, expense for the quarter ending 2026-04-03 was $8.75M, a 18.13% increase year-over-year.
- Enovis Corp share-based payment arrangement, expense for the quarter ending 2025-12-31 was $8.26M, a 5.69% increase year-over-year.
- Enovis Corp share-based payment arrangement, expense for the quarter ending 2025-10-03 was $8.96M, a 14.44% increase year-over-year.
- Enovis Corp share-based payment arrangement, expense for fiscal 2025 was $33.30M, a 12.16% increase from fiscal 2024.
- Enovis Corp share-based payment arrangement, expense for fiscal 2024 was $29.69M, a 7.46% decline from fiscal 2023.
- Enovis Corp share-based payment arrangement, expense for fiscal 2023 was $32.08M, a 1.86% increase from fiscal 2022.
- Enovis Corp share-based payment arrangement, expense for fiscal 2022 was $31.49M, a 22.36% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-07-03 | $8.90M 10-Q · filed 2026-08-06 | $17.65M 10-Q · filed 2026-08-06 | $25.92M derived: sum of 3 quarters · filed 2026-08-06 | $34.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $8.75M 10-Q · filed 2026-05-07 | $17.01M derived: sum of 2 quarters · filed 2026-05-07 | $25.97M derived: sum of 3 quarters · filed 2026-05-07 | $34.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $8.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.22M derived: sum of 2 quarters · filed 2026-02-26 | $25.89M derived: sum of 3 quarters · filed 2026-08-06 | $33.30M 10-K · filed 2026-02-26 |
| 2025-10-03 | $8.96M 10-Q · filed 2025-11-06 | $17.63M derived: sum of 2 quarters · filed 2026-08-06 | $25.03M 10-Q · filed 2025-11-06 | $32.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-07-04 | $8.67M 10-Q · filed 2026-08-06 | $16.07M 10-Q · filed 2026-08-06 | $23.89M derived: sum of 3 quarters · filed 2026-08-06 | $31.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-04-04 | $7.41M 10-Q · filed 2026-05-07 | $15.23M derived: sum of 2 quarters · filed 2026-05-07 | $23.05M derived: sum of 3 quarters · filed 2026-05-07 | $30.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.65M derived: sum of 2 quarters · filed 2026-02-26 | $23.29M derived: sum of 3 quarters · filed 2026-02-26 | $29.69M 10-K · filed 2026-02-26 |
| 2024-09-27 | $7.83M 10-Q · filed 2025-11-06 | $15.47M derived: sum of 2 quarters · filed 2025-11-06 | $21.87M 10-Q · filed 2025-11-06 | $29.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-28 | $7.64M 10-Q · filed 2025-08-07 | $14.04M 10-Q · filed 2025-08-07 | $21.98M derived: sum of 3 quarters · filed 2026-02-26 | $30.34M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-29 | $6.40M 10-Q · filed 2025-05-08 | $14.34M derived: sum of 2 quarters · filed 2026-02-26 | $22.70M derived: sum of 3 quarters · filed 2026-02-26 | $31.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.30M derived: sum of 2 quarters · filed 2026-02-26 | $25.17M derived: sum of 3 quarters · filed 2026-02-26 | $32.08M 10-K · filed 2026-02-26 |
| 2023-09-29 | $8.37M 10-Q · filed 2024-11-06 | $17.23M derived: sum of 2 quarters · filed 2024-11-06 | $24.14M 10-Q · filed 2024-11-06 | $33.90M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $8.87M 10-Q · filed 2024-08-07 | $15.78M 10-Q · filed 2024-08-07 | $25.54M derived: sum of 3 quarters · filed 2025-02-26 | $32.74M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $6.91M 10-Q · filed 2024-05-02 | $16.67M derived: sum of 2 quarters · filed 2025-02-26 | $23.87M derived: sum of 3 quarters · filed 2025-02-26 | $31.69M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $16.96M derived: sum of 2 quarters · filed 2025-02-26 | $24.79M derived: sum of 3 quarters · filed 2025-02-26 | $31.49M 10-K · filed 2025-02-26 |
| 2022-09-30 | $7.21M 10-Q · filed 2023-11-07 | $15.03M derived: sum of 2 quarters · filed 2023-11-07 | $21.73M 10-Q · filed 2023-11-07 | $28.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-01 | $7.82M 10-Q · filed 2023-08-03 | $14.53M 10-Q · filed 2023-08-03 | $21.27M derived: sum of 3 quarters · filed 2024-02-22 | $27.52M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-04-01 | $6.71M 10-Q · filed 2023-05-04 | $13.45M derived: sum of 2 quarters · filed 2024-02-22 | $19.70M derived: sum of 3 quarters · filed 2024-02-22 | $26.49M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $12.99M derived: sum of 2 quarters · filed 2024-02-22 | $19.78M derived: sum of 3 quarters · filed 2024-02-22 | $25.74M 10-K · filed 2024-02-22 |
| 2021-10-01 | $6.25M 10-Q · filed 2022-11-02 | $13.05M derived: sum of 2 quarters · filed 2022-11-02 | $19.00M 10-Q · filed 2022-11-02 | |
| 2021-07-02 | $6.79M 10-Q · filed 2022-08-04 | $12.75M 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $22.50M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |